Your Article Summary
See Latest ArticlesTeva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin (Human Growth Hormone)
Teva Pharmaceutical Industries, 07/01/09
Teva Pharmaceutical Industries Ltd. and its partner, Antares Pharma, Inc. announced the approval of a Supplemental New Drug Application, which added "needle-free injection" to its Tev-Tropin brand human growth hormone drug label. Teva will market the Antares needle-free device as the Tev-Tropin Tjet Injector system.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Valsartan and aliskiren (Valturna): Combination of an angiotensin receptor blocker with direct renin inhibitor approved for the treatment of hypertension
Formulary , 12/02/09
FDA Approval for Uveitis Treatment for Sirion's Durezol
Review of Ophthalmology, 12/02/09
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09